Back

Dynamic changes of genomic and transcriptomic tumor diversity during melanoma progression

Moore, A. L.; Dimitrakopoulos, C.; Flückiger-Mangual, S.; Frischknecht, L.; Beisel, C.; Krek, W.; Beerenwinkel, N.

2021-03-18 cancer biology
10.1101/2021.03.18.435947 bioRxiv
Show abstract

Metastatic melanoma is an aggressive disease that is notoriously difficult to treat. Here, we used a BRAFV600E-driven mouse model to study melanoma progression and metastasis in the absence of extrinsic mutagenic factors such as UV radiation. The tumors were grown for different time periods in seven different mice such that disease progression was tracked over time. We sequenced the whole exome and whole transcriptome of 16 melanoma samples from these mice. The timed samples revealed that many genes are increasingly upregulated during progression, such as genes involved in extracellular matrix organization, and Vegfc, a factor that induces lymphatic vessel growth and metastases to lymph nodes, which was identified as an important signaling hub in our analysis. The Vegfc gene interaction network highlighted multiple genes from the MAPK pathway that are increasingly deregulated during tumor evolution. The genomic diversity of primary and metastatic tumors showed an increase over time. Additionally, our integrative multi-omics analysis adds further evidence that Rock1 is a crucial player driving metastasis formation, and may be upregulated due to mutations in the PI3K/AKT pathway. In summary, our study contributes towards an improved understanding of melanoma which may eventually lead to improved treatment strategies.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.